Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025004941> ?p ?o ?g. }
- W2025004941 endingPage "1883" @default.
- W2025004941 startingPage "1879" @default.
- W2025004941 abstract "It was reported that ritanserin, a 5HT2A/2C antagonist, improves negative symptoms when added to neuroleptics in inpatients with predominantly negative symptoms. Nevertheless, the results of published studies are contradictory so far. This study was designed to investigate the effect of ritanserin added to risperidone as augmentation therapy in patients with chronic schizophrenia and prominent negative symptoms in a double blind and randomized clinical trial. Eligible participants in this study were 40 patients with chronic schizophrenia. All patients were inpatients and were in the active phase of the illness, and met DSM-IV-TR criteria for schizophrenia. Patients were allocated in a random fashion, 20 to risperidone 6 mg/day plus ritanserin 12 mg/day (6 mg bid) and 20 to risperidone 6 mg/day plus placebo. The principal measure of the outcome was Positive and Negative Syndrome Scale (PANSS). Although both protocols significantly decreased the score of the positive, negative and general psychopathological symptoms over the trial period, the combination of risperidone and ritanserin showed a significant superiority over risperidone alone in decreasing negative symptoms and PANSS total scores. The present study indicates ritanserin as a potential adjunctive treatment strategy for the negative symptoms of schizophrenia. Nevertheless, results of larger controlled trials are needed, before recommendation for a broad clinical application can be made." @default.
- W2025004941 created "2016-06-24" @default.
- W2025004941 creator A5023328685 @default.
- W2025004941 creator A5037883760 @default.
- W2025004941 creator A5040471470 @default.
- W2025004941 creator A5056017687 @default.
- W2025004941 creator A5088810181 @default.
- W2025004941 date "2008-12-01" @default.
- W2025004941 modified "2023-09-28" @default.
- W2025004941 title "Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: A double-blind randomized placebo-controlled study" @default.
- W2025004941 cites W162689910 @default.
- W2025004941 cites W1853518047 @default.
- W2025004941 cites W1977233625 @default.
- W2025004941 cites W1997023267 @default.
- W2025004941 cites W2014323153 @default.
- W2025004941 cites W2017096529 @default.
- W2025004941 cites W2018099032 @default.
- W2025004941 cites W2032479290 @default.
- W2025004941 cites W2045658109 @default.
- W2025004941 cites W2048423134 @default.
- W2025004941 cites W2059686805 @default.
- W2025004941 cites W2067098350 @default.
- W2025004941 cites W2087269314 @default.
- W2025004941 cites W2089545943 @default.
- W2025004941 cites W2090471606 @default.
- W2025004941 cites W2095477131 @default.
- W2025004941 cites W2127217405 @default.
- W2025004941 cites W2132887367 @default.
- W2025004941 cites W2140606211 @default.
- W2025004941 cites W2142828574 @default.
- W2025004941 doi "https://doi.org/10.1016/j.pnpbp.2008.08.020" @default.
- W2025004941 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18801405" @default.
- W2025004941 hasPublicationYear "2008" @default.
- W2025004941 type Work @default.
- W2025004941 sameAs 2025004941 @default.
- W2025004941 citedByCount "66" @default.
- W2025004941 countsByYear W20250049412012 @default.
- W2025004941 countsByYear W20250049412013 @default.
- W2025004941 countsByYear W20250049412014 @default.
- W2025004941 countsByYear W20250049412015 @default.
- W2025004941 countsByYear W20250049412016 @default.
- W2025004941 countsByYear W20250049412017 @default.
- W2025004941 countsByYear W20250049412018 @default.
- W2025004941 countsByYear W20250049412019 @default.
- W2025004941 countsByYear W20250049412020 @default.
- W2025004941 countsByYear W20250049412021 @default.
- W2025004941 countsByYear W20250049412022 @default.
- W2025004941 countsByYear W20250049412023 @default.
- W2025004941 crossrefType "journal-article" @default.
- W2025004941 hasAuthorship W2025004941A5023328685 @default.
- W2025004941 hasAuthorship W2025004941A5037883760 @default.
- W2025004941 hasAuthorship W2025004941A5040471470 @default.
- W2025004941 hasAuthorship W2025004941A5056017687 @default.
- W2025004941 hasAuthorship W2025004941A5088810181 @default.
- W2025004941 hasConcept C118552586 @default.
- W2025004941 hasConcept C126322002 @default.
- W2025004941 hasConcept C142724271 @default.
- W2025004941 hasConcept C15744967 @default.
- W2025004941 hasConcept C168563851 @default.
- W2025004941 hasConcept C170493617 @default.
- W2025004941 hasConcept C204787440 @default.
- W2025004941 hasConcept C27081682 @default.
- W2025004941 hasConcept C2776412080 @default.
- W2025004941 hasConcept C2776885963 @default.
- W2025004941 hasConcept C2777450907 @default.
- W2025004941 hasConcept C2778122271 @default.
- W2025004941 hasConcept C2779727114 @default.
- W2025004941 hasConcept C2780057945 @default.
- W2025004941 hasConcept C2780135775 @default.
- W2025004941 hasConcept C71924100 @default.
- W2025004941 hasConceptScore W2025004941C118552586 @default.
- W2025004941 hasConceptScore W2025004941C126322002 @default.
- W2025004941 hasConceptScore W2025004941C142724271 @default.
- W2025004941 hasConceptScore W2025004941C15744967 @default.
- W2025004941 hasConceptScore W2025004941C168563851 @default.
- W2025004941 hasConceptScore W2025004941C170493617 @default.
- W2025004941 hasConceptScore W2025004941C204787440 @default.
- W2025004941 hasConceptScore W2025004941C27081682 @default.
- W2025004941 hasConceptScore W2025004941C2776412080 @default.
- W2025004941 hasConceptScore W2025004941C2776885963 @default.
- W2025004941 hasConceptScore W2025004941C2777450907 @default.
- W2025004941 hasConceptScore W2025004941C2778122271 @default.
- W2025004941 hasConceptScore W2025004941C2779727114 @default.
- W2025004941 hasConceptScore W2025004941C2780057945 @default.
- W2025004941 hasConceptScore W2025004941C2780135775 @default.
- W2025004941 hasConceptScore W2025004941C71924100 @default.
- W2025004941 hasIssue "8" @default.
- W2025004941 hasLocation W20250049411 @default.
- W2025004941 hasLocation W20250049412 @default.
- W2025004941 hasOpenAccess W2025004941 @default.
- W2025004941 hasPrimaryLocation W20250049411 @default.
- W2025004941 hasRelatedWork W1975413208 @default.
- W2025004941 hasRelatedWork W2025004941 @default.
- W2025004941 hasRelatedWork W2038376893 @default.
- W2025004941 hasRelatedWork W2040538157 @default.
- W2025004941 hasRelatedWork W2135419962 @default.
- W2025004941 hasRelatedWork W2253867724 @default.
- W2025004941 hasRelatedWork W2373455425 @default.